The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice

PURPOSE: Currently approved therapies for multiple sclerosis (MS) at best only slow down its progression. Therefore, it is necessary to utilize novel technologies in order to synthesize smart multifunctional structures. In the present study, for the first time we evaluated the therapeutic potential...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fakharzadeh, Saideh, Sahraian, Mohammad Ali, Hafizi, Maryam, Kalanaky, Somayeh, Masoumi, Zahra, Mahdavi, Mehdi, Kamalian, Nasser, Minagar, Alireza, Nazaran, Mohammad Hassan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2014
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137990/
https://ncbi.nlm.nih.gov/pubmed/25143732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S64630
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia